Anastasia Shneyderman

Hong Kong Science And Technology Park, Hong Kong
Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

PCO26-270: Transcriptomic Profiling Reveals Inflammatory and Epithelial-Mesenchymal Transition Pathway Activation in Endoxifen-Resistant Estrogen Receptor-Positive Breast Cancer.

PCO26-270: Transcriptomic Profiling Reveals Inflammatory and Epithelial-Mesenchymal Transition Pathway Activation in Endoxifen-Resistant Estrogen Receptor-Positive Breast Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026

PCO26-270: Transcriptomic Profiling Reveals Inflammatory and Epithelial-Mesenchymal Transition Pathway Activation in Endoxifen-Resistant Estrogen Receptor-Positive Breast Cancer.

PCO26-270: Transcriptomic Profiling Reveals Inflammatory and Epithelial-Mesenchymal Transition Pathway Activation in Endoxifen-Resistant Estrogen Receptor-Positive Breast Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026

Uncovering the transcriptomic basis of endoxifen resistance in ER+ breast cancer cells: Insights from bioinformatics analysis.

Uncovering the transcriptomic basis of endoxifen resistance in ER+ breast cancer cells: Insights from bioinformatics analysis.

Journal: Cancer treatment and research communications
Published: June 01, 2025

Evaluation of (Z)-endoxifen as a potential therapy for glioblastoma multiforme through computational and experimental analyses.

Evaluation of (Z)-endoxifen as a potential therapy for glioblastoma multiforme through computational and experimental analyses.

Journal: Scientific reports
Published: May 09, 2025

From clock to clock: Therapeutic target discovery for aging and age-related diseases.

From clock to clock: Therapeutic target discovery for aging and age-related diseases.

Journal: Ageing research reviews
Published: May 09, 2025

Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.

Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.

Journal: International archives of allergy and immunology
Published: August 17, 2023

Defining the progeria phenome.

Defining the progeria phenome.

Journal: Aging
Published: August 04, 2023

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform.

Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform.

Journal: Aging
Published: February 07, 2023

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.

Journal: Chemical science
Published: October 14, 2022

High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders.

High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders.

Journal: Cell death & disease
Published: July 23, 2022

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.

Journal: Frontiers in aging neuroscience
Published: April 06, 2022

COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.

COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity.

Journal: PLoS computational biology
Published: January 08, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026